Previous Close | 1.0000 |
Open | 1.0500 |
Bid | 0.7500 |
Ask | 2.6500 |
Strike | 10.00 |
Expire Date | 2024-08-16 |
Day's Range | 1.0000 - 1.1000 |
Contract Range | N/A |
Volume | |
Open Interest | 283 |
On May 20, 2024, Bronwen Bastone, Chief People Officer of Enfusion Inc (NYSE:ENFN), executed a sale of 34,059 shares of the company, as reported in a recent SEC Filing.
Enfusion, Inc. (NYSE:ENFN) Q1 2024 Earnings Call Transcript May 11, 2024 Enfusion, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion’s First Quarter 2024 Earnings Conference Call. […]
Enfusion ( NYSE:ENFN ) First Quarter 2024 Results Key Financial Results Revenue: US$48.1m (up 17% from 1Q 2023). Net...